Patients with early recurrence of hepatocellular carcinoma have poor prognosis

被引:0
|
作者
Tomoki Kobayashi [1 ]
Hiroshi Aikata [1 ]
Tsuyoshi Kobayashi [2 ]
Hideki Ohdan [2 ]
Koji Arihiro [3 ]
Kazuaki Chayama [1 ,4 ]
机构
[1] Department of Gastroenterology and Metabolism, Hiroshima University Hospital
[2] Department of Gastroenterological and Transplant Surgery, Applied Life Sciences, Institute of Biomedical and Health Sciences, Hiroshima University
[3] Department of Anatomical Pathology, Hiroshima University Hospital
[4] Liver Research Project Center, Hiroshima University
关键词
early recurrence; small hepatocellular carcinoma; risk factors; beyond the Milan criteria;
D O I
暂无
中图分类号
R735.7 [肝肿瘤];
学科分类号
100214 ;
摘要
BACKGROUND: Early recurrence(ER) after hepatic resection(HR) is a poor prognostic factor for patients with hepatocellular carcinoma(HCC). This study aimed to identify the clinicopathological features, outcomes, and risk factors for ER after HR for small HCC in order to clarify the reasons why ER is a worse recurrence pattern.METHODS: We retrospectively examined 130 patients who underwent HR for small HCC(≤30 mm). Recurrence was classified into ER(<2 years) and late recurrence(LR)(≥2 years). The clinicopathological features, outcomes, and risk factors for ER were analyzed by multivariate analysis.RESULTS: ER was observed in 39 patients(30.0%). The survival rate of the ER group was significantly lower than that of the LR group(P<0.005), and ER was an independent prognostic factor for poor survival(P=0.0001). The ER group had a significantly higher frequency(P=0.0039) and shorter interval(P=0.027) of development to carcinoma beyond the Milan criteria(DBMC) compared with the LR group, and ER was an independent risk factor for DBMC(P<0.0001). Multi-nodularity, non-simple nodular type, and microvascular invasion were independent predictors for ER(P=0.012, 0.010, and 0.019, respectively).CONCLUSIONS: ER was a highly malignant recurrence pattern associated with DBMC and subsequent poor survival after HR for small HCC. Multi-nodularity, non-simple nodular type, and microvascular invasion predict ER, and taking these factors into consideration may be useful for the decision of the treatment strategy for small HCC after HR.
引用
收藏
页码:279 / 288
页数:10
相关论文
共 50 条
  • [1] Patients with early recurrence of hepatocellular carcinoma have poor prognosis
    Kobayashi, Tomoki
    Aikata, Hiroshi
    Kobayashi, Tsuyoshi
    Ohdan, Hideki
    Arihiro, Koji
    Chayama, Kazuaki
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2017, 16 (03) : 279 - 288
  • [2] Expression of prothymosin α predicts early recurrence and poor prognosis of hepatocellular carcinoma
    Ha, Sang Yun
    Song, Dae Hyun
    Hwang, Soo Hyun
    Cho, Soo Youn
    Park, Cheol-Keun
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2015, 14 (02) : 171 - 177
  • [3] Expression of prothymosin α predicts early recurrence and poor prognosis of hepatocellular carcinoma
    Sang Yun Ha
    Dae Hyun Song
    Soo Hyun Hwang
    Soo Youn Cho
    Cheol-Keun Park
    Hepatobiliary&PancreaticDiseasesInternational, 2015, 14 (02) : 171 - 177
  • [4] Patients with polyclonal hepatocellular carcinoma are at a high risk of early recurrence and have a poor recurrence-free survival period
    Kaibori, Masaki
    Sakai, Kazuko
    Matsushima, Hideyuki
    Kosaka, Hisashi
    Matsui, Kosuke
    De Velasco, Marco A.
    Sekimoto, Mitsugu
    Nishio, Kazuto
    HEPATOLOGY INTERNATIONAL, 2022, 16 (01) : 135 - 147
  • [5] Patients with polyclonal hepatocellular carcinoma are at a high risk of early recurrence and have a poor recurrence-free survival period
    Masaki Kaibori
    Kazuko Sakai
    Hideyuki Matsushima
    Hisashi Kosaka
    Kosuke Matsui
    Marco A. De Velasco
    Mitsugu Sekimoto
    Kazuto Nishio
    Hepatology International, 2022, 16 : 135 - 147
  • [6] ASPM is a novel marker for vascular invasion, early recurrence, and poor prognosis of hepatocellular carcinoma
    Lin, Shih-Yeh
    Pan, Hung-Wei
    Liu, Shu-Hsiang
    Jeng, Yung-Ming
    Hu, Fu-Chang
    Peng, Shian-Yang
    Lai, Po-Lin
    Hsu, Hey-Chi
    CLINICAL CANCER RESEARCH, 2008, 14 (15) : 4814 - 4820
  • [7] Akt phosphorylation is a risk factor for early disease recurrence and poor prognosis in hepatocellular carcinoma
    Nakanishi, K
    Sakamoto, M
    Yamasaki, S
    Todo, S
    Hirohashi, S
    CANCER, 2005, 103 (02) : 307 - 312
  • [8] The prognosis and the recurrence of RFA treated patients with hepatocellular carcinoma
    Takigawa, Atsuo
    Sakamori, Ryotaro
    Tatsumi, Tomohide
    Yakushijin, Takayuki
    Kegasawa, Tadashi
    Makino, Yuki
    Tawara, Seiichi
    Saito, Yoshinobu
    Onishi, Yoshiki
    Tanaka, Satoshi
    Furuta, Kunimaro
    Shigekawa, Minoru
    Hikita, Hayato
    Hiramatsu, Naoki
    Takehara, Tetsuo
    HEPATOLOGY, 2015, 62 : 437A - 438A
  • [9] NDRG1 as a biomarker for metastasis, recurrence and of poor prognosis in hepatocellular carcinoma
    Cheng, Jun
    Xie, Hai-Yang
    Xu, Xiao
    Wu, Jian
    Wei, Xuyong
    Su, Rong
    Zhang, Wu
    Lv, Zhen
    Zheng, Shusen
    Zhou, Lin
    CANCER LETTERS, 2011, 310 (01) : 35 - 45
  • [10] Preoperative elevated plasma fibrinogen level predicts tumor recurrence and poor prognosis in patients with hepatocellular carcinoma
    Dai, Tianxing
    Peng, Lingrong
    Lin, Guozhen
    Li, Yang
    Yao, Jia
    Deng, Yinan
    Li, Hua
    Wang, Genshu
    Liu, Wei
    Yang, Yang
    Chen, Guihua
    Wang, Guoying
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2019, 10 (06) : 1049 - 1063